Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription Articles published in Brain Res Retrieve available abstracts of 185 articles: HTML format

Single Articles

November 2026
1. WANG C, Huang W, Zhang W, Zhang L, et al
   Astragalin ameliorates cognitive dysfunction in Alzheimer's disease model mice: Role of the iron metabolism-autophagy axis.
   Brain Res. 2026 Nov 5:150626. doi: 10.1016/j.brainres.2026.150626.
   PubMed     Abstract available
   
   
   October 2026
2. LOU H, Huang C, Shen J, Wang D, et al
   Plasma p-tau181, Abeta1-42, and GFAP across Alzheimer's disease, mixed-type Alzheimer's disease, mild cognitive impairment, anxiety disorders, and depressive disorders.
   Brain Res. 2026 Oct 23:150606. doi: 10.1016/j.brainres.2026.150606.
   PubMed     Abstract available
   
   
   
3. WANG Y, Qin S, Gong X, Bai H, et al
   A promising therapeutic strategy reduces abnormal Abeta deposition and inhibits neuronal apoptosis via FGF17 ameliorating AD-like neurodegeneration.
   Brain Res. 2026;1889:150474.
   PubMed     Abstract available
   
   
   
4. TOYOKAWA M, Yasuda K, Kikuya A, Asada-Utsugi M, et al
   Amyloid-beta1-42 oligomers compromise oligodendrocyte precursor cells and disrupt blood-brain barrier integrity in vitro.
   Brain Res. 2026;1888:150436.
   PubMed     Abstract available
   
   
   
5. XUAN Z, Rahman MU, Ilyas M, Alioui Y, et al
   Gut bacterial isolates from individuals with Alzheimer's disease induce strain-specific intestinal, inflammatory, and neurobehavioral phenotypes in mice.
   Brain Res. 2026 Oct 1:150569. doi: 10.1016/j.brainres.2026.150569.
   PubMed     Abstract available
   
   
   September 2026
6. JUNWU F, Xiangqian R, Chengyong Y, Dai K, et al
   Alzheimer's disease-associated transcriptional signatures define prognostic subtypes in glioma.
   Brain Res. 2026 Sep 18:150525. doi: 10.1016/j.brainres.2026.150525.
   PubMed     Abstract available
   
   
   
7. ROBLIN L, Sampson H, Murillo I, Lake R, et al
   Evaluation of open field movement organization and spatial orientation in 5xFAD mice.
   Brain Res. 2026;1887:150393.
   PubMed     Abstract available
   
   
   
8. LI Y, Lu C, Liu N, Wang X, et al
   Integrated proteomics and network pharmacology reveal autophagy-lysosomal regulation underlying sulforaphane-mediated neuroprotection in Alzheimer's disease.
   Brain Res. 2026 Sep 14:150549. doi: 10.1016/j.brainres.2026.150549.
   PubMed     Abstract available
   
   
   August 2026
9. MARAKHOVSKAYA YA, Churov AV, Arbatsky MS, Sergeeva SP, et al
   Ferroptosis and Alzheimer's disease: Neuroimmune crosstalk and pharmacological opportunities.
   Brain Res. 2026 Aug 21:150514. doi: 10.1016/j.brainres.2026.150514.
   PubMed     Abstract available
   
   
   
10. TANI H
    A replicated astrocyte long non-coding RNA signature of Alzheimer's disease is inverted in amyotrophic lateral sclerosis.
    Brain Res. 2026 Aug 21:150513. doi: 10.1016/j.brainres.2026.150513.
    PubMed     Abstract available
    
    
    
11. LI Y, Chen J
    Lentinan attenuates tau phosphorylation and memory deficits in hTau-overexpressing mice.
    Brain Res. 2026;1885:150340.
    PubMed     Abstract available
    
    
    
12. MATUSZEWSKA M, Cieslik M, Sulejczak D, Wilkaniec A, et al
    BET protein inhibitor JQ1 reduces inflammationand hippocampal amyloid-beta level without altering Tau phosphorylation in LPS-challenged adult wild-type mice.
    Brain Res. 2026;1884:150318.
    PubMed     Abstract available
    
    
    July 2026
13. LIU Y, Li Y, Zhou Y, Hei Y, et al
    STAT3 mediated the isoleucine-induced Alzheimer's disease progression.
    Brain Res. 2026 Jul 18:150472. doi: 10.1016/j.brainres.2026.150472.
    PubMed     Abstract available
    
    
    
14. CHEN W, Su F, Kong H, Wang Y, et al
    APOE genotype and astrocyte activity collectively influence AD biomarkers and Abeta burden.
    Brain Res. 2026;1883:150283.
    PubMed     Abstract available
    
    
    
15. HOUMAM S, Siodlak D, Seshadri M, Hallum GB, et al
    Cell-specific expression of APP and GABA(B)R1 isoforms in wild-type and the APP NL-G-F mouse model of Alzheimer's disease.
    Brain Res. 2026 Jul 9:150463. doi: 10.1016/j.brainres.2026.150463.
    PubMed     Abstract available
    
    
    May 2026
16. LIU Y, Li L, Pu J, Xiong Y, et al
    Early and sustained Intervention with YKB Modulates the Cerebro-Retinal-Synaptic Network to Ameliorate Memory Deficits in Alzheimer's Disease.
    Brain Res. 2026 May 30:150396. doi: 10.1016/j.brainres.2026.150396.
    PubMed     Abstract available
    
    
    
17. SARKO LE, Klaus E, Bondarenko V, Secker C, et al
    uPAR exhibits age- and region-dependent expression in the brains of mice with Alzheimer's disease-like pathology.
    Brain Res. 2026;1886:150364.
    PubMed     Abstract available
    
    
    April 2026
18. SIS CO, Yildiz O, Elci MP, Fatsa T, et al
    Neuroprotective and therapeutic effects of magnesium L-threonate in an amyloid beta(1-42) induced SH-SY5Y cell model of Alzheimer's disease.
    Brain Res. 2026 Apr 21:150341. doi: 10.1016/j.brainres.2026.150341.
    PubMed    
    
    
    
19. XU G, Gao J, Wang T, Wu H, et al
    Differential modulation of EEG microstate spatiotemporal dynamics by rTMS and iTBS correlates with clinical improvement in Alzheimer's disease.
    Brain Res. 2026;1884:150323.
    PubMed     Abstract available
    
    
    March 2026
20. MIAO Z, Yang Z, Huang Q, Fan J, et al
    Ding-zhi-xiao-wan attenuates Alzheimer's disease pathology and cognitive deficits in mouse model.
    Brain Res. 2026;1881:150263.
    PubMed     Abstract available
    
    
    
21. LI J, Wang C, Zhang JH, Cai JM, et al
    Retraction notice to "Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress" [Brain Res. 1328 (2010) 152-161].
    Brain Res. 2026 Mar 6:150251. doi: 10.1016/j.brainres.2026.150251.
    PubMed    
    
    
    
22. CORIA-LUCERO C, Lopez M, Gomez-Mejiba S, Ramirez D, et al
    Daily temporal organization of inflammation and cognition-related factors and antioxidant enzymes are modified by an intracerebroventricular injection of amyloid-beta peptide (1-42) aggregates in the rat temporal cortex.
    Brain Res. 2026;1874:150135.
    PubMed     Abstract available
    
    
    February 2026
23. ZHENG M, Su W, Tian L, Gao W, et al
    The glymphatic system as a brain scavenger in Alzheimer's disease: mechanisms and therapeutic implications.
    Brain Res. 2026;1880:150221.
    PubMed     Abstract available
    
    
    
24. MANASA M, Bethanagere Ramesha G, Krishna KL, Ambika MS, et al
    Harnessing estrogen's neuroprotective potential in mitigating Alzheimer's pathologies in postmenopausal women: a review.
    Brain Res. 2026;1879:150226.
    PubMed     Abstract available
    
    
    January 2026
25. CADAXO AS, Cotrin JC, Valente AP, Lopes FG, et al
    Multi-biofluid metabolomics coupled with gene network reveals stage-specific alterations in mild cognitive impairment and Alzheimer's disease in an ethnically mixed cohort.
    Brain Res. 2026;1874:150167.
    PubMed     Abstract available
    
    
    
26. PARIYA GHOLIZADEH DANGHERALOU , Khazaeifard F, Mehr SR, Mansouri SM, et al
    Evaluation of neurobiochemical and behavioral responses to carvone nanoemulsion: A neuroprotective approach for Alzheimer's disease-associated dementia in a rat model.
    Brain Res. 2026 Jan 2:150143. doi: 10.1016/j.brainres.2026.150143.
    PubMed     Abstract available
    
    
    
27. WU H, Liu L, Zeng L
    Advances in plasma biomarkers for the diagnosis of Alzheimer's disease.
    Brain Res. 2026;1874:150138.
    PubMed     Abstract available
    
    
    December 2025
28. YUAN J, Zhang J, Zhang H, Tu Y, et al
    Propofol induces mitochondrial dysfunction in hippocampal neurons and postoperative cognitive dysfunction in male 3xTg-AD mice by blocking ESRRG-mediated HSD11B2 transcription.
    Brain Res. 2025;1869:150035.
    PubMed     Abstract available
    
    
    
29. MAJUMDER M, Dutta D, Paidi RK, Pahan K, et al
    Activation of PPARalpha by gemfibrozil lowers tau-associated neuropathology in the MAPT mouse model of Alzheimer's disease.
    Brain Res. 2025 Dec 7:150089. doi: 10.1016/j.brainres.2025.150089.
    PubMed     Abstract available
    
    
    
30. REYES H, Mondragon J, Frank C, Murphy C, et al
    Examining functional connectivity in metabolic syndrome and small vessel disease: A novel approach to understanding olfactory dysfunction and Alzheimer's disease.
    Brain Res. 2025 Dec 1:150084. doi: 10.1016/j.brainres.2025.150084.
    PubMed     Abstract available
    
    
    November 2025
31. HUI S, Long Y, Zhu L, Shi W, et al
    IGF2BP2-mediated m6A modification of IGF1R mRNA promotes neuronal senescence and cognitive decline in Alzheimer's disease.
    Brain Res. 2025;1871:150067.
    PubMed     Abstract available
    
    
    
32. SARDARI M, Sahafi OH, Rezayof A
    Mitochondria serve as indispensable components of neuron-glia crosstalk in the trajectory of Alzheimer's disease.
    Brain Res. 2025 Nov 18:150040. doi: 10.1016/j.brainres.2025.150040.
    PubMed     Abstract available
    
    
    
33. VLACHOS I, Moschovos C, Apostolakopoulou L, Karasavvidou K, et al
    Resting EEG partial coherence demonstrates increased gamma range central functional connectivity in amnestic mild cognitive impairment.
    Brain Res. 2025;1867:149973.
    PubMed     Abstract available
    
    
    
34. SHARMA A, Singh TG
    Next-generation neurotherapeutics: mechanistic insights on monoclonal antibodies in Alzheimer's disease.
    Brain Res. 2025;1870:150047.
    PubMed     Abstract available
    
    
    October 2025
35. LIU Z, Kuang L, Zhou X, Zhao J, et al
    Effect of the plasma lipidome, immune cells, inflammatory proteins, gut microbiota, and plasma metabolites on Alzheimer's Disease: A two-sample Mendelian randomized study and mediation analysis.
    Brain Res. 2025;1869:150009.
    PubMed     Abstract available
    
    
    
36. BI D, Gao B, Shen Y, Dai Z, et al
    Traumatic brain injury and neurodegenerative diseases: the role of axonal injury and amyloid-beta.
    Brain Res. 2025;1865:149873.
    PubMed     Abstract available
    
    
    
37. ISMAIL A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, et al
    Astrocyte response in Alzheimer's disease: Good or bad?
    Brain Res. 2025 Oct 6:149971. doi: 10.1016/j.brainres.2025.149971.
    PubMed     Abstract available
    
    
    
38. DING Z, Wang J, Ding W, Duan Y, et al
    Calycosin improved long-term memory impairment in the very early of APP/PS1 mice.
    Brain Res. 2025;1864:149789.
    PubMed     Abstract available
    
    
    
39. GENG D, Liu A, Yan Y, Zheng W, et al
    Intermittent ELF-MF exposure effectively ameliorates pathologic features associated with adult AD mice.
    Brain Res. 2025;1864:149796.
    PubMed     Abstract available
    
    
    September 2025
40. WANG Y, Zhao D, Kong T, Ni Y, et al
    Associations between reproductive milestones and Alzheimer's disease risk: a Mendelian randomization study.
    Brain Res. 2025;1867:149972.
    PubMed     Abstract available
    
    
    
41. KAKOTY V, Goh KW, Kesharwani P, Ko YT, et al
    BNIP3L/NIX-mediated mitophagy: Future directions in Alzheimer's disease.
    Brain Res. 2025;1867:149970.
    PubMed     Abstract available
    
    
    
42. MAK KK, Nam KJ, Chuang YF, Chen LK, et al
    Matrix metalloproteinases and tissue inhibitors of metalloproteinases as the biomarkers of Alzheimer's disease: a meta-analysis.
    Brain Res. 2025 Sep 23:149954. doi: 10.1016/j.brainres.2025.149954.
    PubMed     Abstract available
    
    
    
43. AKASH A, Ahamed M, Porel P, Aran KR, et al
    Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications.
    Brain Res. 2025 Sep 19:149949. doi: 10.1016/j.brainres.2025.149949.
    PubMed     Abstract available
    
    
    
44. HU X, Morihara R, Fukui Y, Bian Y, et al
    Spearmint extract Neumentix downregulates amyloid-beta accumulation by promoting phagocytosis in APP23 mice.
    Brain Res. 2025;1863:149752.
    PubMed     Abstract available
    
    
    
45. SHENG J, Zhu H, Zhou R, Zhang Q, et al
    Bridging the gap between structural and metabolic neuroimaging via MRI-to-PET synthesis: A tri-attention enhanced GAN approach.
    Brain Res. 2025;1862:149691.
    PubMed     Abstract available
    
    
    August 2025
46. CAM OZUNLU SA, Uysal F, Tatli Dogan H, Parlar A, et al
    Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model of Alzheimer's disease.
    Brain Res. 2025;1866:149918.
    PubMed     Abstract available
    
    
    
47. LI J, Wang C, Zhang JH, Cai JM, et al
    Expression of concern: "Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress" [BRAIN RES, Volume 1328 (2010) 152-161].
    Brain Res. 2025;1861:149685.
    PubMed    
    
    
    
48. MOHAN M, Mannan A, Singh S, Singh TG, et al
    Unlocking the cellular mystery: how proton pump inhibitors may alter the dementia landscape.
    Brain Res. 2025;1861:149702.
    PubMed     Abstract available
    
    
    
49. LIU B, Ahmad MA, Abbas G, Ahmed U, et al
    From particulates to pathways: environmental exposures and their impact on Alzheimer's disease.
    Brain Res. 2025 Aug 8:149880. doi: 10.1016/j.brainres.2025.149880.
    PubMed     Abstract available
    
    
    
50. LIU L, Jiang M, Zhang Y, Lv L, et al
    Acori Tatarinowii Rhizoma inhibited neuroinflammation in Alzheimer's disease rats by modulating the intestinal flora.
    Brain Res. 2025 Aug 8:149878. doi: 10.1016/j.brainres.2025.149878.
    PubMed     Abstract available
    
    
    July 2025
51. ALOUANI Z, Gannour OE, Saleh S, El-Ibrahimi A, et al
    A novel contrastive Dual-Branch Network (CDB-Net) for robust EEG-Based Alzheimer's disease diagnosis.
    Brain Res. 2025;1865:149863.
    PubMed     Abstract available
    
    
    
52. WANG Y, Mu D, Li Y, Liu C, et al
    Alzheimer's disease: a jigsaw puzzle comprised of different types of programmed cell death pieces.
    Brain Res. 2025;1865:149861.
    PubMed     Abstract available
    
    
    
53. ISLAM MA, Kshirsagar S, Alvir RV, Pradeepkiran JA, et al
    Overexpressed MicroRNA-455-3p enhances cognitive function in late-onset Alzheimer's disease.
    Brain Res. 2025 Jul 21:149853. doi: 10.1016/j.brainres.2025.149853.
    PubMed     Abstract available
    
    
    
54. YAO M, Liu A, Song J, Xing L, et al
    The impact of epigenetic and epitranscriptomic modifications on Alzheimer's disease: the mysteries of DNA, RNA, and histone methylation.
    Brain Res. 2025;1865:149852.
    PubMed     Abstract available
    
    
    
55. SALGADO KDCB, Nascimento RGF, Albuquerque ALS, Oliveira LAM, et al
    Melatonin protects mouse hippocampal neurons from neurotoxicity induced by amyloid beta-peptide(25-35).
    Brain Res. 2025;1859:149637.
    PubMed     Abstract available
    
    
    
56. BASHIR DJ, Bhat KA, Bashir M
    Deciphering Alzheimer's disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier.
    Brain Res. 2025;1863:149828.
    PubMed     Abstract available
    
    
    
57. BALL BK, Kuhn MK, Fleeman Bechtel RM, Proctor EA, et al
    Metabolites associated with type 2 diabetes and Alzheimer's disease trigger differential intracellular signaling responses in mouse primary neurons.
    Brain Res. 2025;1864:149819.
    PubMed     Abstract available
    
    
    June 2025
58. HE J, Ran M, Tam KY
    An orally administered quinolinium molecule mitigates neuropathology of Alzheimer's disease through modulation of mitochondrial dysfunction and neuroinflammation.
    Brain Res. 2025 Jun 25:149804. doi: 10.1016/j.brainres.2025.149804.
    PubMed     Abstract available
    
    
    
59. MA XH, Dai H, Liu SY, Liu XN, et al
    Protection of dauricine and daurisoline on PC12 cells damaged by glutamate or Abeta(25-35).
    Brain Res. 2025;1857:149609.
    PubMed     Abstract available
    
    
    
60. KHAN G, Hussain MS, Khan Y, Fatima R, et al
    Ferroptosis and its contribution to cognitive impairment in Alzheimer's disease: mechanisms and therapeutic potential.
    Brain Res. 2025 Jun 9:149776. doi: 10.1016/j.brainres.2025.149776.
    PubMed     Abstract available
    
    
    May 2025
61. ARIOZ BI, Binokay L, Tastan B, Genc B, et al
    Characterization of tRNA-derived fragments in the small neuron-derived extracellular vesicles of Alzheimer's disease patients.
    Brain Res. 2025;1862:149730.
    PubMed     Abstract available
    
    
    
62. CHAVEZ-LOPEZ LM, Silvestre-Martinez JH, Del Carmen Lugo-Ibarra K, Castro-Cesena AB, et al
    A comprehensive approach to Alzheimer's Disease: Exploring Nanotechnology, treatment Innovations, and sex differences.
    Brain Res. 2025 May 26:149718. doi: 10.1016/j.brainres.2025.149718.
    PubMed     Abstract available
    
    
    
63. YANG X, Jiang M, Wu M, Jin X, et al
    Crocin drives intestinal microbiota variation in a rat model of Alzheimer's disease by reducing DKK3 expression.
    Brain Res. 2025;1862:149734.
    PubMed     Abstract available
    
    
    
64. ZHOU Q, Huang X, Chen Z, Wang F, et al
    Mechanism of Rhizoma Polygonati in the treatment of Alzheimer's disease based on network pharmacology and molecular docking.
    Brain Res. 2025 May 22:149680. doi: 10.1016/j.brainres.2025.149680.
    PubMed     Abstract available
    
    
    
65. SOLEIMANI Z, Davoudi S, Saffarzadeh F, Behzadi G, et al
    Restoring neuronal excitability and spatial memory through inhibiting amyloid-beta-induced hyperactive NF-kappaB in a rat model of Alzheimer's disease.
    Brain Res. 2025;1861:149703.
    PubMed     Abstract available
    
    
    
66. KAUR J, Sharma V, Khan H, Singh S, et al
    Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential.
    Brain Res. 2025;1855:149568.
    PubMed     Abstract available
    
    
    
67. SHAHID F, Khan R, Mehmood A, Smadi AA, et al
    A comprehensive approach to anticipating the progression of mild cognitive impairment.
    Brain Res. 2025;1855:149549.
    PubMed     Abstract available
    
    
    
68. XU C
    Enhanced social interaction protects cognition by preserving synapse numbers.
    Brain Res. 2025;1854:149552.
    PubMed     Abstract available
    
    
    April 2025
69. MIYAZAKI H, Ide K, Yamaguchi H, Ogawa M, et al
    Peripheral lymphocyte counts and regional cerebral blood flow on brain SPECT correlate in Alzheimer's disease: A retrospective cross-sectional study.
    Brain Res. 2025;1859:149657.
    PubMed     Abstract available
    
    
    
70. AHSAN R, Khan MM, Mishra A, Noor G, et al
    Plumbagin as a potential therapeutic agent for scopolamine-induced Alzheimer's disease: Mechanistic insights into GSK-3beta inhibition.
    Brain Res. 2025 Apr 16:149650. doi: 10.1016/j.brainres.2025.149650.
    PubMed     Abstract available
    
    
    
71. FANG L, Fu X, Yu Y, Liu D, et al
    Collaborative multitasking framework for enhanced hippocampus segmentation and Alzheimer's disease classification.
    Brain Res. 2025;1858:149610.
    PubMed     Abstract available
    
    
    
72. AKBARI F, Soheilian R, Tavalaeian S, Zamani A, et al
    Alterations in NFAT5 and ATP6V1E1 expression as potential diagnostic biomarkers in blood and brain for Alzheimer's disease: A study of gene overlap.
    Brain Res. 2025 Apr 3:149599. doi: 10.1016/j.brainres.2025.149599.
    PubMed     Abstract available
    
    
    
73. RADBAKHSH S, Abrego-Guandique DM, Bacchetti T, Aghaee-Bakhtiari SH, et al
    Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer's disease under intravenous trehalose treatment.
    Brain Res. 2025;1857:149607.
    PubMed     Abstract available
    
    
    
74. CHIANG MC, Nicol CJB, Yang YP, Chiang T, et al
    The alpha-MG exhibits neuroprotective potential by reducing amyloid beta peptide-induced inflammation, oxidative stress, and tau aggregation in human neural stem cells.
    Brain Res. 2025;1852:149506.
    PubMed     Abstract available
    
    
    March 2025
75. KARIM F, Ngo A, Danh TB, Delaney BA, et al
    Reduction in [(18)F]Nifene Binding, a PET imaging Probe for alpha4beta2* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer's disease brain.
    Brain Res. 2025;1857:149600.
    PubMed     Abstract available
    
    
    
76. KAZEMI M, Sanati M, Shekari Khaniani M, Ghafouri-Fard S, et al
    A review on the lncRNA-miRNA-mRNA regulatory networks involved in inflammatory processes in Alzheimer's disease.
    Brain Res. 2025;1856:149595.
    PubMed     Abstract available
    
    
    
77. JAIN S, Murmu A, Chauhan A
    Advancing Alzheimer's disease therapy through engineered exosomal Macromolecules.
    Brain Res. 2025;1855:149590.
    PubMed     Abstract available
    
    
    
78. PINKY, Anwar S, Neha, Parvez S, et al
    Paeoniflorin inhibits pyruvate dehydrogenase kinase 3 and promotes BDNF activity by modulating neuronal activity and TNF-alpha.
    Brain Res. 2025;1851:149476.
    PubMed     Abstract available
    
    
    
79. ABDEL-AAL RA, Meligy FY, Maghraby N, Sayed N, et al
    Comparing levetiracetam and zonisamide effects on rivastigmine anti-Alzheimer's activity in aluminum chloride-induced Alzheimer's-like disease in rats: Impact on alpha7 nicotinic acetylcholine receptors and amyloid beta.
    Brain Res. 2025;1855:149573.
    PubMed     Abstract available
    
    
    
80. ZHENG C, Zhao Y, Hu C, Zhang L, et al
    Transcriptomic and network analysis identifies shared pathways across Alzheimer's disease and vascular dementia.
    Brain Res. 2025 Mar 3:149548. doi: 10.1016/j.brainres.2025.149548.
    PubMed     Abstract available
    
    
    
81. DERAFSHPOUR L, Niazi M, Pourheydar B, Roshan-Milani S, et al
    Aging and voluntary exercise's effects on Abeta1-42 levels, endoplasmic reticulum stress factors, and apoptosis in the hippocampus of old male rats.
    Brain Res. 2025;1850:149447.
    PubMed     Abstract available
    
    
    
82. GUTIERRE RC, Rocha PR, Graciani AL, Coppi AA, et al
    Tau, amyloid, iron, oligodendrocytes ferroptosis, and inflammaging in the hippocampal formation of aged rats submitted to an aerobic exercise program.
    Brain Res. 2025;1850:149419.
    PubMed     Abstract available
    
    
    
83. WANG R, Azad AK, Sheikh AM, Tabassum S, et al
    Carboxylated Zn-phthalocyanine attenuates brain Abeta in AD model mouse.
    Brain Res. 2025;1850:149422.
    PubMed     Abstract available
    
    
    February 2025
84. GHADGE SR, Shimpi PH, Kumbhar VV, Khairnar B, et al
    Comprehensive evaluation of AChE inhibition by Eulophia ochreata extract Utilizing in Silico, ex Vivo, and in vivo zebrafish models.
    Brain Res. 2025 Feb 24:149531. doi: 10.1016/j.brainres.2025.149531.
    PubMed     Abstract available
    
    
    
85. TIAN Y, Li W, Zhang Y
    3-N-Butylphthalide alleviate Abeta-induced cellular senescence through the CDK2-pRB1-Caspase3 axis.
    Brain Res. 2025;1849:149435.
    PubMed     Abstract available
    
    
    
86. WANG L, Li W, Wu W, Liu Q, et al
    Effects of electroacupuncture on microglia phenotype and epigenetic modulation of C/EBPbeta in SAMP8 mice.
    Brain Res. 2025;1849:149339.
    PubMed     Abstract available
    
    
    
87. ZHAO X, Zhou Q, Zhang H, Ono M, et al
    Olfactory deprivation promotes amyloid beta deposition in a mouse model of Alzheimer's disease.
    Brain Res. 2025;1851:149500.
    PubMed     Abstract available
    
    
    
88. DHAPOLA R, Kumari S, Sharma P, Vellingiri B, et al
    Advancements in autophagy perturbations in Alzheimer's disease: Molecular aspects and therapeutics.
    Brain Res. 2025;1851:149494.
    PubMed     Abstract available
    
    
    January 2025
89. LI W, Yong-Yan X, Jia-Xin M, Shu-Chao G, et al
    Senescent microglia: The hidden culprits accelerating Alzheimer's disease.
    Brain Res. 2025 Jan 28:149480. doi: 10.1016/j.brainres.2025.149480.
    PubMed     Abstract available
    
    
    
90. CHIARINI A, Armato U, Gui L, Yin M, et al
    Early divergent modulation of NLRP2's and NLRP3's inflammasome sensors vs. AIM2's one by signals from Abeta.Calcium-sensing receptor complexes in human astrocytes.
    Brain Res. 2025;1846:149283.
    PubMed     Abstract available
    
    
    December 2024
91. ZHANG Z, Zhang S, Liu S, He Y, et al
    Fuzhisan ameliorates cognitive ability in Alzheimer's disease by p62 and related autophagy regulatory pathways.
    Brain Res. 2024;1849:149436.
    PubMed     Abstract available
    
    
    
92. YANG Q, Chen T, Li S, Yang C, et al
    Inhibition of autophagy attenuates cognitive decline and mitochondrial dysfunction in an Alzheimer's disease mouse model with chronic cerebral hypoperfusion.
    Brain Res. 2024;1850:149416.
    PubMed     Abstract available
    
    
    
93. XIE Y, Yang M, Wang H, Chen Y, et al
    Potential molecular mechanisms of tobacco smoke exposure in Alzheimer's disease.
    Brain Res. 2024;1848:149394.
    PubMed     Abstract available
    
    
    
94. CHEN J, Zhang M, Shen Z, Tang M, et al
    Low-dose diazepam improves cognitive function in APP/PS1 mouse models: Involvement of AMPA receptors.
    Brain Res. 2024;1845:149207.
    PubMed     Abstract available
    
    
    
95. DE SOUSA RAL, Mendes BF
    T-regulatory cells and extracellular vesicles in Alzheimer's disease: New therapeutic concepts and hypotheses.
    Brain Res. 2024;1850:149393.
    PubMed     Abstract available
    
    
    
96. SUN S, Cui C, Li Y, Meng Y, et al
    A Machine learning classification framework using fused fractal property feature vectors for Alzheimer's disease diagnosis.
    Brain Res. 2024 Dec 3:149373. doi: 10.1016/j.brainres.2024.149373.
    PubMed     Abstract available
    
    
    November 2024
97. CHEN Z, Zheng N, Wang F, Zhou Q, et al
    The role of ferritinophagy and ferroptosis in Alzheimer's disease.
    Brain Res. 2024 Nov 23:149340. doi: 10.1016/j.brainres.2024.149340.
    PubMed     Abstract available
    
    
    
98. LIN L, Li J, Yu Z, He J, et al
    Nrf2 activator tertiary butylhydroquinone enhances neural stem cell differentiation and implantation in Alzheimer's disease by boosting mitochondrial function.
    Brain Res. 2024 Nov 18:149341. doi: 10.1016/j.brainres.2024.149341.
    PubMed     Abstract available
    
    
    
99. PATTANAIK S, Prusty SK, Sahu PK
    Exploring DPP IV inhibitors for Alzheimer's disease: Bridging diabetes and neurodegeneration.
    Brain Res. 2024 Nov 18:149342. doi: 10.1016/j.brainres.2024.149342.
    PubMed     Abstract available
    
    
    
100. MAHMUD JOY MA, Nasrin S, Siddiqua A, Farid DM, et al
     ViTAD: Leveraging Modified Vision Transformer for Alzheimer's Disease Multi-Stage Classification from Brain MRI Scans.
     Brain Res. 2024 Nov 11:149302. doi: 10.1016/j.brainres.2024.149302.
     PubMed     Abstract available
     
     
     
101. ZHANG T, Yang J, Xu H, Cao Y, et al
     Acorus tatarinowii alleviates D-galactose-induced Alzheimer's-like disease cognitive impairment and Abeta-induced pericytes dysfunction in mice.
     Brain Res. 2024 Nov 6:149312. doi: 10.1016/j.brainres.2024.149312.
     PubMed     Abstract available
     
     
     
102. DING X, Liu F, Wang H, Wang Y, et al
     Ganoderic acid a decreased Abeta42-induced neurotoxicity in PC12 cells by reduced mitochondrial damage.
     Brain Res. 2024;1842:149102.
     PubMed     Abstract available
     
     
     
103. DIVYA R, Shantha Selva Kumari R
     Multi-instance learning attention model for amyloid quantification of brain sub regions in longitudinal cognitive decline.
     Brain Res. 2024;1842:149103.
     PubMed     Abstract available
     
     
     October 2024
104. SEREBROVSKA Z, Xi L, Fedoriuk M, Dosenko V, et al
     Intermittent hypoxia-hyperoxia training ameliorates cognitive impairment and neuroinflammation in a rat model of Alzheimer's disease.
     Brain Res. 2024 Oct 28:149301. doi: 10.1016/j.brainres.2024.149301.
     PubMed     Abstract available
     
     
     
105. GANESH A, Choudhury W, Coutellier L
     Early spatial recognition memory deficits in 5XFAD female mice are associated with disruption of prefrontal parvalbumin neurons.
     Brain Res. 2024;1841:149122.
     PubMed     Abstract available
     
     
     
106. XIA N, Xu L, Xu D, Huang M, et al
     Neuroprotective effect of emodin on Abeta(25-35)-induced cytotoxicity in PC12 cells involves Nrf2/GPX4 and TLR4/p-NF-kappaB/NLRP3 pathways.
     Brain Res. 2024;1841:149019.
     PubMed     Abstract available
     
     
     
107. MAFTOON H, Davar Siadat S, Tarashi S, Soroush E, et al
     Ameliorative effects of Akkermansia muciniphila on anxiety-like behavior and cognitive deficits in a rat model of Alzheimer's disease.
     Brain Res. 2024 Oct 15:149280. doi: 10.1016/j.brainres.2024.149280.
     PubMed     Abstract available
     
     
     
108. PARKER J, Moris JM, Goodman LC, Paidisetty VK, et al
     A multifactorial lens on risk factors promoting the progression of Alzheimer's disease.
     Brain Res. 2024;1846:149262.
     PubMed     Abstract available
     
     
     September 2024
109. ASADIFARD E, Hokmabadi M, Hashemi M, Bereimipour A, et al
     Linking gut microbiota dysbiosis to molecular pathways in Alzheimer's disease.
     Brain Res. 2024 Sep 16:149242. doi: 10.1016/j.brainres.2024.149242.
     PubMed     Abstract available
     
     
     
110. WANG W, Xia H
     The role of lipid species in Alzheimer's disease onset: A comprehensive Mendelian randomization analysis.
     Brain Res. 2024 Sep 13:149238. doi: 10.1016/j.brainres.2024.149238.
     PubMed     Abstract available
     
     
     
111. HAN R, Zhang X, Chen Y, Hou X, et al
     Associations between differential connectivity patterns of executive control networks and APOE varepsilon4 in the Alzheimer continuum.
     Brain Res. 2024 Sep 8:149229. doi: 10.1016/j.brainres.2024.149229.
     PubMed     Abstract available
     
     
     August 2024
112. THAPA R, Ahmad Bhat A, Shahwan M, Ali H, et al
     Proteostasis disruption and senescence in Alzheimer's disease pathways to neurodegeneration.
     Brain Res. 2024;1845:149202.
     PubMed     Abstract available
     
     
     
113. ZHANG QX, Zhang LJ, Zhao N, Yang L, et al
     Irisin in ischemic Stroke, Alzheimer's disease and Depression: A narrative review.
     Brain Res. 2024 Aug 28:149192. doi: 10.1016/j.brainres.2024.149192.
     PubMed     Abstract available
     
     
     
114. SINGH M, Ali H, Renuka Jyothi S, Kaur I, et al
     Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer's disease.
     Brain Res. 2024;1844:149165.
     PubMed     Abstract available
     
     
     
115. ZHONG F, Xiong L, Wu J, Chen Y, et al
     The KEAP1/PGAM5/AIFM1-Mediated oxeiptosis pathway in Alzheimer's disease.
     Brain Res. 2024 Aug 19:149173. doi: 10.1016/j.brainres.2024.149173.
     PubMed     Abstract available
     
     
     
116. BREEZE B, Connell E, Wileman T, Muller M, et al
     Menopause and Alzheimer's disease susceptibility: Exploring the potential mechanisms.
     Brain Res. 2024 Aug 18:149170. doi: 10.1016/j.brainres.2024.149170.
     PubMed     Abstract available
     
     
     
117. MCCLARTY BM, Rodriguez G, Dong H
     Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP/PS1 mice.
     Brain Res. 2024;1837:148951.
     PubMed     Abstract available
     
     
     July 2024
118. SMITH T, Knudsen KJ, Ritchie SA
     A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer's disease.
     Brain Res. 2024 Jul 23:149132. doi: 10.1016/j.brainres.2024.149132.
     PubMed     Abstract available
     
     
     
119. ABUDUAINI Y, Chen W, Kong XZ
     Handedness in Alzheimer's disease: A systematic review.
     Brain Res. 2024 Jul 23:149131. doi: 10.1016/j.brainres.2024.149131.
     PubMed     Abstract available
     
     
     June 2024
120. SUN S, Lu W, Zhang C, Wang G, et al
     Folic acid and S-adenosylmethionine reverse Homocysteine-induced Alzheimer's disease-like pathological changes in rat hippocampus by modulating PS1 and PP2A methylation levels.
     Brain Res. 2024 Jun 23:149095. doi: 10.1016/j.brainres.2024.149095.
     PubMed     Abstract available
     
     
     
121. DE LOURDES SIGNORINI-SOUZA I, Tureck LV, Batistela MS, Coutinho de Almeida R, et al
     The potential of five c-miRNAs as serum biomarkers for Late-Onset Alzheimer's disease diagnosis: miR-10a-5p, miR-29b-2-5p, miR-125a-5p, miR-342-3p, and miR-708-5p.
     Brain Res. 2024 Jun 14:149090. doi: 10.1016/j.brainres.2024.149090.
     PubMed     Abstract available
     
     
     
122. RUSSO ML, Ayala G, Neal D, Rogalsky AE, et al
     Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice.
     Brain Res. 2024 Jun 10:149083. doi: 10.1016/j.brainres.2024.149083.
     PubMed     Abstract available
     
     
     
123. WANG Y, Wu LH, Hou F, Wang ZJ, et al
     Mitochondrial calcium uniporter knockdown in hippocampal neurons alleviates anxious and depressive behavior in the 3XTG Alzheimer's disease mouse model.
     Brain Res. 2024 Jun 6:149060. doi: 10.1016/j.brainres.2024.149060.
     PubMed     Abstract available
     
     
     May 2024
124. FARHATULLAH, Chen X, Zeng D, Mehmood A, et al
     3-Way hybrid analysis using clinical and magnetic resonance imaging for early diagnosis of Alzheimer's disease.
     Brain Res. 2024 May 27:149021. doi: 10.1016/j.brainres.2024.149021.
     PubMed     Abstract available
     
     
     
125. BHADANE P, Roul K, Belemkar S, Kumar D, et al
     Immunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress.
     Brain Res. 2024 May 21:149018. doi: 10.1016/j.brainres.2024.149018.
     PubMed     Abstract available
     
     
     
126. ZHOU Q, Xu L
     The regulation of BAI1 in astrocytes through the STAT3/EZH2 axis relieves neuronal apoptosis in rats with Alzheimer's disease.
     Brain Res. 2024;1839:149007.
     PubMed     Abstract available
     
     
     
127. LIU X, Chen J, Du Y, Tian Q, et al
     The changes of neurogenesis in the hippocampal dentate gyrus of SAMP8 mice and the effects of acupuncture and moxibustion.
     Brain Res. 2024;1831:148814.
     PubMed     Abstract available
     
     
     
128. CHEN Y, Li Y, Wu M, Li Z, et al
     Electroacupuncture improves cognitive function in APP/PS1 mice by inhibiting oxidative stress related hippocampal neuronal ferroptosis.
     Brain Res. 2024;1831:148744.
     PubMed     Abstract available
     
     
     
129. FU Y, Xie GM, Liu RQ, Xie JL, et al
     From aberrant neurodevelopment to neurodegeneration: Insights into the hub gene associated with autism and alzheimer's disease.
     Brain Res. 2024;1838:148992.
     PubMed    
     
     
     
130. CHANG CJ, Taoufiq Z, Yamada H, Kohji T, et al
     The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer's disease model mice.
     Brain Res. 2024 May 6:148987. doi: 10.1016/j.brainres.2024.148987.
     PubMed     Abstract available
     
     
     
131. PEI MQ, Xu LM, Yang YS, Chen WC, et al
     Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders.
     Brain Res. 2024;1830:148821.
     PubMed     Abstract available
     
     
     
132. HE R, Al-Tamimi J, Sanchez-Benavides G, Montana-Valverde G, et al
     Atypical cortical hierarchy in Abeta-positive older adults and its reflection in spontaneous speech.
     Brain Res. 2024;1830:148806.
     PubMed     Abstract available
     
     
     April 2024
133. FOROUGHI S, Shahanipour K, Monajemi R, Ahadi AM, et al
     Investigating the effects of Thymus vulgaris essential oil, Allium cepa extract, and their active compounds (thymol and quercetin) on expression profile of genes related to Alzheimer's disease in PC12 model cell.
     Brain Res. 2024 Apr 28:148966. doi: 10.1016/j.brainres.2024.148966.
     PubMed     Abstract available
     
     
     
134. NEFODOVA A, Rudyk M, Dovhyi R, Dovbynchuk T, et al
     Systemic inflammation in Abeta(1-40)-induced Alzheimer's disease model: New translational opportunities.
     Brain Res. 2024;1837:148960.
     PubMed     Abstract available
     
     
     
135. XIE Y, Li X, Shi Q, Le L, et al
     The synergistic effect of curcumin and mitoquinol mesylate on cognitive impairment and the neuropathology of Alzheimer's disease.
     Brain Res. 2024;1837:148959.
     PubMed     Abstract available
     
     
     
136. BEIYU Z, Rong Z, Yi Z, Shan W, et al
     Oxidative stress is associated with Abeta accumulation in chronic sleep deprivation model.
     Brain Res. 2024;1829:148776.
     PubMed     Abstract available
     
     
     
137. CLELAND NRW, Potter GJ, Buck C, Quang D, et al
     Altered metabolism and DAM-signatures in female brains and microglia with aging.
     Brain Res. 2024;1829:148772.
     PubMed     Abstract available
     
     
     
138. HAN L, Chen W, Li J, Zhao Y, et al
     Palmatine improves cognitive dysfunction in Alzheimer's disease model rats through autophagy pathway and regulation of gut microbiota.
     Brain Res. 2024;1835:148932.
     PubMed     Abstract available
     
     
     
139. UCHIUMI O, Zou J, Yamaki S, Hori Y, et al
     Disruption of sphingomyelin synthase 2 gene alleviates cognitive impairment in a mouse model of Alzheimer's disease.
     Brain Res. 2024;1835:148934.
     PubMed     Abstract available
     
     
     
140. YANG Y, Jia X, Yang X, Wang J, et al
     Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
     Brain Res. 2024;1835:148920.
     PubMed     Abstract available
     
     
     
141. REZAUL ISLAM M, Akash S, Murshedul Islam M, Sarkar N, et al
     Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights.
     Brain Res. 2024 Apr 4:148886. doi: 10.1016/j.brainres.2024.148886.
     PubMed     Abstract available
     
     
     
142. KUSHAWAHA SK, Ashawat MS, Soni D, Kumar P, et al
     Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer's disease.
     Brain Res. 2024;1834:148906.
     PubMed     Abstract available
     
     
     March 2024
143. KAUR K, Kulkarni YA, Wairkar S
     Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems.
     Brain Res. 2024;1834:148905.
     PubMed     Abstract available
     
     
     
144. ANSARI MA, Al-Jarallah A, Rao MS, Babiker A, et al
     Upregulation of NADPH-oxidase, inducible nitric oxide synthase and apoptosis in the hippocampus following impaired insulin signaling in the rats: Development of sporadic Alzheimer's disease.
     Brain Res. 2024;1834:148890.
     PubMed     Abstract available
     
     
     
145. GENG C, Tan L, Chenchen
     Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
     Brain Res. 2024 Mar 20:148881. doi: 10.1016/j.brainres.2024.148881.
     PubMed     Abstract available
     
     
     
146. WANG Y, Song C, Yin G, Meng Y, et al
     Alleviation of behavioral deficits, amyloid-beta deposition, and mitochondrial structure damage associated with mitophagy upregulation in AD animal models via AAV9-IGF-1 treatment.
     Brain Res. 2024;1827:148743.
     PubMed     Abstract available
     
     
     
147. LIU R, Guo L, Zhao Y, Wu D, et al
     Study on multi-target effects of the novel HDAC6 inhibitor W5 on Abeta/Cu(2+)-induced Alzheimer's disease model of rats.
     Brain Res. 2024;1832:148847.
     PubMed     Abstract available
     
     
     
148. MERCERON-MARTINEZ D, Alacan Ricardo L, Bejerano Pina A, Orama Rojo N, et al
     Amylovis-201 enhances physiological memory formation and rescues memory and hippocampal cell loss in a streptozotocin-induced Alzheimer's disease animal model.
     Brain Res. 2024 Mar 1:148848. doi: 10.1016/j.brainres.2024.148848.
     PubMed     Abstract available
     
     
     February 2024
149. WANG W, Zheng WQ, Du X, Chen SC, et al
     Chronic pain exacerbates memory impairment and pathology of Abeta and tau by upregulating IL-1beta and p-65 signaling in a mouse model of Alzheimer's disease.
     Brain Res. 2024 Feb 29:148843. doi: 10.1016/j.brainres.2024.148843.
     PubMed     Abstract available
     
     
     
150. ZHANG Z, Ding C, Fu R, Wang J, et al
     Low-frequency rTMS modulated the excitability and high-frequency firing in hippocampal neurons of the Alzheimer's disease mouse model.
     Brain Res. 2024 Feb 24:148822. doi: 10.1016/j.brainres.2024.148822.
     PubMed     Abstract available
     
     
     
151. PUMO A, Legeay S
     The dichotomous activities of microglia: A potential driver for phenotypic heterogeneity in Alzheimer's disease.
     Brain Res. 2024 Feb 21:148817. doi: 10.1016/j.brainres.2024.148817.
     PubMed     Abstract available
     
     
     
152. MANTELLATTO GRIGOLI M, Pelegrini LNC, Whelan R, Cominetti MR, et al
     Present and Future of Blood-Based Biomarkers of Alzheimer's Disease: Beyond the Classics.
     Brain Res. 2024;1830:148812.
     PubMed     Abstract available
     
     
     
153. SHARMA M, Pal P, Gupta SK
     The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons.
     Brain Res. 2024;1829:148797.
     PubMed     Abstract available
     
     
     
154. DHEVII MANOHARAN S, Abdul Hamid H, Fariesha Md Hashim N, Singh Cheema M, et al
     Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
     Brain Res. 2024 Feb 1:148793. doi: 10.1016/j.brainres.2024.148793.
     PubMed     Abstract available
     
     
     January 2024
155. TSAMOU M, Roggen EL
     Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD).
     Brain Res. 2024 Jan 31:148791. doi: 10.1016/j.brainres.2024.148791.
     PubMed     Abstract available
     
     
     
156. LANDIN-ROMERO R, Kumfor F, Ys Lee A, Leyton C, et al
     Clinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing.
     Brain Res. 2024;1829:148777.
     PubMed     Abstract available
     
     
     
157. ZHAI Y, Morihara R, Feng T, Hu X, et al
     Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3/PIM1/NFATc1 axis, in a novel mouse model of Alzheimer's disease with cerebral hypoperfusion.
     Brain Res. 2024 Jan 23:148790. doi: 10.1016/j.brainres.2024.148790.
     PubMed     Abstract available
     
     
     
158. VALIPOUR B, Simorgh S, Mirsalehi M, Moradi S, et al
     Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer's disease rat model.
     Brain Res. 2024;1828:148764.
     PubMed     Abstract available
     
     
     
159. BELVIRANLI M, Okudan N
     Coconut oil ameliorates behavioral and biochemical alterations induced by D-GAL/AlCl(3) in rats.
     Brain Res. 2024;1823:148704.
     PubMed     Abstract available
     
     
     
160. MAJOU D, Dermenghem AL
     Effects of DHA (omega-3 fatty acid) and estradiol on amyloid beta-peptide regulation in the brain.
     Brain Res. 2024;1823:148681.
     PubMed     Abstract available
     
     
     
161. CHEN H, Yang X, Gao Y, Jiang H, et al
     Electroacupuncture ameliorates cognitive impairment in APP/PS1 mouse by modulating TFEB levels to relieve ALP dysfunction.
     Brain Res. 2024;1823:148683.
     PubMed     Abstract available
     
     
     
162. CHEN P, Zhang S, Zhao K, Kang X, et al
     Robustly uncovering the heterogeneity of neurodegenerative disease by using data-driven subtyping in neuroimaging: A review.
     Brain Res. 2024;1823:148675.
     PubMed     Abstract available
     
     
     
163. KEIL J, Kiiski H, Doherty L, Hernandez-Urbina V, et al
     Artificial sharp-wave-ripples to support memory and counter neurodegeneration.
     Brain Res. 2024;1822:148646.
     PubMed     Abstract available
     
     
     December 2023
164. MIAO J, Liu X, Lan J
     40 Hz Electroacupuncture relieves the memory dysfunction of 5xFAD mice by regulating neuronal electrical activity.
     Brain Res. 2023;1821:148576.
     PubMed     Abstract available
     
     
     
165. YANG Y, Wang J, Ni H, Ding H, et al
     Genetic model of selective COX2 inhibition improve learning and memory ability and brain pathological changes in 5xFAD mouse.
     Brain Res. 2023;1821:148566.
     PubMed     Abstract available
     
     
     
166. YU H, Morihara R, Ota-Elliott R, Bian Z, et al
     Injection of exogenous amyloid-beta oligomers aggravated cognitive deficits, and activated necroptosis, in APP23 transgenic mice.
     Brain Res. 2023;1821:148565.
     PubMed     Abstract available
     
     
     
167. WANG X, Gan W, Kang M, Lv C, et al
     Asthma aggravates alzheimer's disease by up-regulating NF- kappaB signaling pathway through LTD4.
     Brain Res. 2023 Dec 11:148711. doi: 10.1016/j.brainres.2023.148711.
     PubMed     Abstract available
     
     
     November 2023
168. AMIR A, Shahid M, Farooq Khan S, Nisar U, et al
     Nicotinic acid modulates microglial TREM-2 gene in Phytohaemagglutinin-Induced in vitro model of Alzheimer's disease like pathology.
     Brain Res. 2023;1824:148686.
     PubMed     Abstract available
     
     
     
169. WANG Y, Gong Q, Pan H, Wang X, et al
     Gardenia jasminoides J. Ellis extract attenuates memory impairment in rats with Alzheimer's disease by suppressing NLRP3 inflammasome.
     Brain Res. 2023;1824:148687.
     PubMed     Abstract available
     
     
     October 2023
170. XIAOMEI L, Tianyuyi F, Erheng C, Li Y, et al
     A rat model established by simulating genetic-environmental interactions recapitulates human Alzheimer's disease pathology.
     Brain Res. 2023 Oct 31:148663. doi: 10.1016/j.brainres.2023.148663.
     PubMed     Abstract available
     
     
     
171. HASHEMI SA, Ghadimi Z, Ghaedi H, Hashemi A, et al
     The effect of eight weeks of aerobic training with vitamin C on the expression pathway of antioxidants in the hippocampus tissue of TMT induced Alzheimer's disease rats.
     Brain Res. 2023 Oct 21:148645. doi: 10.1016/j.brainres.2023.148645.
     PubMed     Abstract available
     
     
     
172. HENRY SM, Kistler SA, Lagani GD, Bartling CRO, et al
     Tight control of the APP-Mint1 interaction in regulating amyloid production.
     Brain Res. 2023;1817:148496.
     PubMed     Abstract available
     
     
     
173. MOAZZAM F, Hatamian-Zarmi A, Ebrahimi Hosseinzadeh B, Khodagholi F, et al
     Preparation and characterization of brain-targeted polymeric nanocarriers (Frankincense-PMBN-lactoferrin) and in-vivo evaluation on an Alzheimer's disease-like rat model induced by scopolamine.
     Brain Res. 2023;1822:148622.
     PubMed     Abstract available
     
     
     
174. MALIK R, Kalra S, Pooja, Singh G, et al
     Antioxidative and neuroprotective potential of Acorus calamus linn. and Cordia dichotoma G. Forst. In Alzheimer's type dementia in rodent.
     Brain Res. 2023 Oct 2:148616. doi: 10.1016/j.brainres.2023.148616.
     PubMed     Abstract available
     
     
     September 2023
175. LIAN X, Zhang X, Chen W, Xue F, et al
     Dexmedetomidine mitigates neuroinflammation in an Alzheimer's disease mouse model via the miR-204-3p/FBXL7 signaling axis.
     Brain Res. 2023 Sep 29:148612. doi: 10.1016/j.brainres.2023.148612.
     PubMed     Abstract available
     
     
     
176. ASAMU MO, Oladipo OO, Abayomi OA, Adebayo AA, et al
     Alzheimer's disease: The role of T lymphocytes in neuroinflammation and neurodegeneration.
     Brain Res. 2023 Sep 19:148589. doi: 10.1016/j.brainres.2023.148589.
     PubMed     Abstract available
     
     
     
177. ARULCHELVAN E, Vanneste S
     Promising neurostimulation routes for targeting the hippocampus to improve episodic memory: A review.
     Brain Res. 2023;1815:148457.
     PubMed     Abstract available
     
     
     August 2023
178. WANG Y, Shen Z, Wu H, Yu Z, et al
     Identification of genes related to glucose metabolism and analysis of the immune characteristics in Alzheimer's disease.
     Brain Res. 2023 Aug 22:148545. doi: 10.1016/j.brainres.2023.148545.
     PubMed     Abstract available
     
     
     
179. MISHRA M, Raik S, Rattan V, Bhattacharyya S, et al
     Mitochondria transfer as a potential therapeutic mechanism in Alzheimer's disease-like pathology.
     Brain Res. 2023 Aug 22:148544. doi: 10.1016/j.brainres.2023.148544.
     PubMed    
     
     
     
180. ADEKUNLE BABALOLA J, Lang M, George M, Stracke A, et al
     Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.
     Brain Res. 2023 Aug 12:148518. doi: 10.1016/j.brainres.2023.148518.
     PubMed     Abstract available
     
     
     
181. QIN Y, Bai D, Tang M, Zhang M, et al
     Ketogenic diet alleviates brain iron deposition and cognitive dysfunction via Nrf2-mediated ferroptosis pathway in APP/PS1 mouse.
     Brain Res. 2023;1812:148404.
     PubMed     Abstract available
     
     
     June 2023
182. CHAVAN RS, Supalkar KV, Sadar SS, Vyawahare NS, et al
     ANIMAL MODELS OF ALZHEIMER'S DISEASE: AN ORIGINOF INNOVATIVETREATMENTS AND INSIGHT TO THE DISEASE'S ETIOLOGY.
     Brain Res. 2023 Jun 9:148449. doi: 10.1016/j.brainres.2023.148449.
     PubMed     Abstract available
     
     
     
183. KOSE S, Kutlu MD, Kara S, Polat S, et al
     Investigation of the protective effect of long-term exercise on molecular pathways and behaviours in scopolamine induced alzheimer's disease-like condition.
     Brain Res. 2023 Jun 1:148429. doi: 10.1016/j.brainres.2023.148429.
     PubMed     Abstract available
     
     
     May 2023
184. HASAN SMN, Clarke C, Strand T, Bambico FR, et al
     Putative pathological mechanisms of late-life depression and Alzheimer's disease.
     Brain Res. 2023;1813:148423.
     PubMed     Abstract available
     
     
     April 2023
185. CORIA-LUCERO C, Castro A, Ledezma C, Leporatti J, et al
     An intracerebroventricular injection of ABeta (1-42) modifies temporal profiles of spatial memory performance and oxidative status in the temporal cortex rat.
     Brain Res. 2023;1804:148242.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum